Replies to post #218740 on Avid Bioservices Inc (CDMO)

[biopharm]

So the statement "BMS has a long record of buying small bios after failed trials at CSM" seems to be fully erroneous.

My mistake on the IMCLONE deal. BMS only owned 17% and they still bid $4.5B and their bid failed.

As for "BMS has a long record of buying small bios after failed trials at CSM" is still not proved erroneous just yet. Do you have the full list of biotechs that BMS were involved in? We shall come back to this...

[asmarterwookie]

Inhibitex was bought out by BMY.....

http://news.bms.com/press-release/partnering-news/bristol-myers-squibb-acquire-inhibitex

Inhibitex had "dealings" with CSM.

I hear there was a dose switch there as well, perpetrated by CSM....

Not sure if it was ever made public though....



wook

[PastPresentFuture]

You can try asking CloakedProtector on his Post #216978 he might have more info on that.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=113096999